Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportMolecular Targeting Technologies - Radioactive and Nonradioactive Probes: Dosimetry & Image Analysis

Patient-individualized dosimetry via semi-automated CT segmentation and voxel-based Monte Carlo transport methods

Susan Kost, S. Kevin Zhou and Michael Stabin
Journal of Nuclear Medicine May 2011, 52 (supplement 1) 1460;
Susan Kost
3Physics and Astronomy, Vanderbilt University, Nashville, TN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
S. Kevin Zhou
2Government Research Program, Siemens Corporate Research, Princeton, NJ
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Stabin
1Radiology and Radiological Sciences, Vanderbilt University, Nashville, TN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

1460

Objectives Monte Carlo methods using heterogeneous body models (phantoms) are in routine use for performing dose calculations for standardized individuals (e.g. the RADAR ICRP-89 phantom series, using the GEANT4 Monte Carlo transport code). These image-based models are represented in voxel format, with homogeneous activity distributions assumed within source organs. This technology has now been extended to allow input of individual patient anatomic and functional data, to perform 3D dose calculations with heterogeneous activity distributions in organs and tumors.

Methods We have established a method that uses a network of anatomical landmarks to quickly parse 3D CT data and estimate the locations and boundaries of organs present. When important organs are identified and segmented, they are assigned the usual code numbers used in our established GEANT4 transport codes to obtain 3D maps of absorbed dose. To date we have used a single SPECT or PET scan to determine activity distributions, with multiple planar images to establish the kinetics of individual regions, but we intend to ultimately work with multiple SPECT/PET scan data.

Results Using this approach, the segmentation of seven organs and detection of 19 body landmarks can be obtained in under a minute with high accuracy and has been validated against manual segmentation on 80 CT full or partial body scans; errors are typically a few mm. Manual adjustment and segmentation of small objects complements the semi-automated processes. An entire 3D dose work-up is provided by the Monte Carlo code in about 12 hours, with errors mostly around 5%, except for very small organs or tumors, for which more run time can be allotted if needed to improve accuracy.

Conclusions These robust methods provide a tool that can provide accurate, patient-specific 3D dosimetry in times that may be applied in routine clinical practice for radiopharmaceutical therapy

Back to top

In this issue

Journal of Nuclear Medicine
Vol. 52, Issue supplement 1
May 2011
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Patient-individualized dosimetry via semi-automated CT segmentation and voxel-based Monte Carlo transport methods
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Patient-individualized dosimetry via semi-automated CT segmentation and voxel-based Monte Carlo transport methods
Susan Kost, S. Kevin Zhou, Michael Stabin
Journal of Nuclear Medicine May 2011, 52 (supplement 1) 1460;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Patient-individualized dosimetry via semi-automated CT segmentation and voxel-based Monte Carlo transport methods
Susan Kost, S. Kevin Zhou, Michael Stabin
Journal of Nuclear Medicine May 2011, 52 (supplement 1) 1460;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Molecular Targeting Technologies - Radioactive and Nonradioactive Probes: Dosimetry & Image Analysis

  • BAY 94-9392: A novel F-18 labeled tumor specific probe for PET/CT imaging - Dosimetry
  • Whole-body distribution and radiation dosimetry of [11C]telmisartan as a biomarker for hepatic organic anion transporting polypeptide (OATP) 1B3
  • F-18 FDG PET imaging in pregnancy and fetal radiation dose estimates
Show more Molecular Targeting Technologies - Radioactive and Nonradioactive Probes: Dosimetry & Image Analysis

Dosimetry & Image Analysis Posters

  • BAY 94-9392: A novel F-18 labeled tumor specific probe for PET/CT imaging - Dosimetry
  • F-18 FDG PET imaging in pregnancy and fetal radiation dose estimates
  • Radiation exposure by (-)-F18-NCFHEB, a new PET tracer for imaging of cerebral alpha4beta2 nicotinic acetylcholine receptors (nAChRs)
Show more Dosimetry & Image Analysis Posters

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire